XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.26.1

SCHEDULE OF WARRANT ACTIVITY (Details) - $ / shares | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2026 | Jun. 30, 2025 | Dec. 31, 2025 | Dec. 31, 2024
Equity [Abstract] |  |  |  |
Warrants Outstanding, Beginning balance | 13,086,220 | 6,718,176 | 6,718,176 |
Weighted Average Exercise Price, Beginning balance | $ 1.92 | $ 2.37 | $ 2.37 |
Weighted Average Remaining Contractual Term in Years | 3 years 3 months 10 days | 4 years 7 months 13 days | 3 years 9 months 10 days | 4 years 6 months 21 days
Warrants, Issued |  | 3,644,299 |  |
Weighted Average Exercise Price, Issued |  | $ 4.04 |  |
Warrants Outstanding, Exercised |  | 219,283 |  |
Weighted Average Exercise Price, Exercised |  | $ (1.50) |  |
Warrants, Expired |  |  |  |
Weighted Average Exercise Price, Expired |  |  |  |
Warrants Outstanding, Ending balance | 13,086,220 | 10,143,192 | 13,086,220 | 6,718,176
Weighted Average Exercise Price, Ending balance | $ 1.92 | $ 2.17 | $ 1.92 | $ 2.37
Warrants, Exercised |  | (219,283) |  |

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price. + References No definition available. + Details
Name: | MAIA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
Namespace Prefix: | MAIA_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments expirations in period weighted average exercise price. + References No definition available. + Details
Name: | MAIA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsInPeriodWeightedAverageExercisePrice
Namespace Prefix: | MAIA_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. + References No definition available. + Details
Name: | MAIA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
Namespace Prefix: | MAIA_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. + References No definition available. + Details
Name: | MAIA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
Namespace Prefix: | MAIA_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. + References No definition available. + Details
Name: | MAIA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2
Namespace Prefix: | MAIA_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of non-option equity instruments exercised by participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Net number of non-option equity instruments granted to participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant